matt

This is why $MU is NOT a buy today ‼️ They have a 60% Net Margins and this is NOT sustainable! I want to remember you this is a Memory Chip company and they’re HIGH Cyclical! For some reference $NVDA has a 55% Net Margins (Which has one of the most phenomenal Net Margins) BUT they also have the best Chips. Check the image for a better idea on how the margins swing.

$DARE – THE REVENUE ENGINE STARTS NOW. We aren't just watching a chart; we are watching a company flip the switch from R&D to commercial revenue. After a decade of preparation, price is entering its most explosive phase yet. The "High-Velocity" Catalysts: - Q2 Revenue Launch: Disbursing for DARE to PLAY™ and Flora Sync LF5™ is expected to begin THIS QUARTER. We are weeks away from the first-ever product revenue hitting the balance sheet. - 100% Asset Ownership: Bayer returned full rights to Ovaprene® just in time for the Phase 3 home stretch. Daré now keeps 100% of the value for this first-in-category monthly non-hormonal contraceptive. - Non-Dilutive Power: While others dilute, $DARE is fueling its pipeline with NIH, Gates Foundation, and ARPA-H grants. The FDA also just cleared the IND for DARE-HPV to start Phase 2. The Technical Precision: - Macro Wedge Snap: On the weekly chart, $DARE has officially pierced the multi-year descending resistance line. - TTM Squeeze: Maximum compression is over. We are seeing the first momentum shifts toward a massive volatility expansion. - The Gap to $6.11: With the trendline broken, the technical path to the 200-week MA ($6.11) is a +197% air pocket. The accumulation is finished. The commercial era has begun.